Parameters | Patients no (%) |
---|---|
Sex | Â |
Male | 413 (95.3%) |
Female | 20 (4.6%) |
T stage | Â |
T1a | 324 (74.8%) |
T1b | 109 (25.1%) |
Grade | Â |
Well differentiated | 154 (35.5%) |
Mod differentiated | 273 (63.0%) |
Poorly differentiated | 6 (1.3%) |
AC involvement | Â |
Yes | 197 (45.4%) |
No | 236 (54.1%) |
Hemoglobin level | Â |
≤ 13 g/dL | 45 (10.4%) |
> 13 g/dL | 388 (89.6%) |
Field size (cm2) | Â |
< 30.5 | 215 |
30.5-35.5 | 165 |
≥ 35.5 | 53 |
A. Dose fraction size | Â |
2.5 Gy | 177 (40.8) |
Total dose (Gy) | Â |
55 | 30 (6.9) |
57.5 | 134 (30.9) |
60 | 13 (3.0) |
Tx duration (days) | Â |
≤ 30 | 25 (5.7) |
31-33 | 141 (32.5) |
≥ 34 | 11 (2.5) |
BEDcGy15 (cGy) | Â |
Median | 6520 |
range | 6058-6820 |
B. Dose fraction size | Â |
2.0 Gy | 256 (59.1) |
Total dose (Gy) | Â |
64 | 52 (12.0) |
66 | 202 (46.6) |
68 | 2 (0.46) |
Tx duration (days) | Â |
≤ 45 | 48 (11.0) |
46-50 | 203 (46.8) |
≥ 51 | 5 (1.5) |
BEDcGy15 (cGy) | Â |
Median | 6340 |
range | 6040-6700 |